Description:
CALGB-40903 OPEN Registration Worksheet Letrozole in Treating Postmenopausal Women With Ductal Carcinoma in Situ Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B163AFA0-47EE-9956-E040-BB89AD4304B2
Link:
https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B163AFA0-47EE-9956-E040-BB89AD4304B2Keywords:
Versions (3)
- 8/27/12 8/27/12 -
- 1/9/15 1/9/15 - Martin Dugas
- 1/9/15 1/9/15 - Martin Dugas
Uploaded on:
January 9, 2015
DOI:
To request one please log in.License :
Creative Commons BY-NC 3.0 LegacyModel comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Breast Cancer NCT01439711 Registration - CALGB-40903 OPEN Registration Worksheet - 3302958v1.0
Phase II Study of Neoadjuvant Letrozole for Postmenopausal Women with Estrogen Receptor Positive Ductal Carcinoma In Situ (DCIS) NOTE: In the 'Create New' screen of the OPEN application, select the optional Embedded Companion studies (CALGB-151008 and/or CALGB-61105) to which the patient has consented.
- StudyEvent: CALGB-40903 OPEN Registration Worksheet